Nobilis Health's Kolin Ozonian Interviewed by The Life

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nobilis Health's Kolin Ozonian Interviewed by The Life Sciences Report

SAN FRANCISCO, CA --(Marketwired - May 26, 2016) - Managing both acquisitions and internal growth at the same time is difficult for most small companies, akin to drinking water and singing at the same time. Not so for Nobilis Health Corp.   ( NYSE : HLTH ) ( TSX : NHC ), which is orchestrating the flow of new patients to its ambulatory surgical centers while it adds an ensemble of new clinics, resulting in harmonious revenue. The conductor is merger-and-acquisition specialist Kolin Ozonian, who brings years of business development experience in large-cap healthcare to this small-cap enterprise. In this interview with The Life Sciences Report , Ozonian discusses his company's newest technology and talks about how Nobilis will achieve critical mass.

The Life Sciences Report : The Q1/16 numbers for Nobilis Health Corp. were very positive. I noted from your press release that your revenue increased by $13.4 million ($13.4M) to $51.3M in Q1, which was record revenue for you. That represents a 35% increase over Q1/15. You acquired the three new centers last year, but what other factors were responsible for that growth?

Kolin Ozonian : You nailed it on the head in terms of acquiring the three new facilities in the past year. But I think it's important to note that our acquisitions of late have been surgical hospitals . The difference between a surgical hospital and a surgical center is that surgical hospitals enable surgeons to do much more complex procedures, which can have up to a 72-hour inpatient cycle, whereas at an ambulatory surgical center, the patient goes home the same day. The physicians operating in the surgical hospitals are able to do more complex procedures to help patients, but at the same time these facilities are outside the traditional big-hospital model, where patients may be in beds for long periods of time. Our surgical hospitals are state-of-the-art and top-of-the-line, where complex surgical procedures that command a higher fee are performed.

Continue reading this interview: How Nobilis Health Will Break Out of the Healthcare Payment Mold

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that help you capitalize on developing trends.

DISCLOSURE:

Nobilis Health Corp. paid Streetwise Reports to produce and distribute this interview. Kolin Ozonian had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Mr. Ozonian and not of Streetwise Reports or its officers. The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Please see Streetwise Reports' terms of use and full legal disclaimer .

Forward Looking Statements:

This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. 

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission. 

Jim Patrick Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 38

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 301

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 105

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 23

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 5

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 92

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Comercial Português Adresses Legal Risks of FX Mortgages

Updated Category News Views 191

Understanding Legal Risks in FX Mortgage Loans Banco Comercial Português, S.A. is proactive in addressing estimated legal risks associated with the foreign exchange (FX) mortgage loans portfolio managed by Bank Millennium, S.A. This initiative reflects the bank's commitment to stability and customer security amidst a complex financial landscape. Estimated Provisions for...

Continue Reading
Elevating Dating: MillionaireMatch's New Travel Feature

Updated Category News Views 117

Introducing the New Feature on MillionaireMatch MillionaireMatch, the renowned dating website catering to billionaires and successful individuals, has launched an exciting new feature known as 'Willing to Fly to Meet.' This update empowers users to indicate their readiness to travel distances for a potential romantic connection. By opting into this feature, individuals...

Continue Reading
Whistle Design Sparks Innovation for Coaches and Trainers

Updated Category News Views 151

So, here’s the lowdown: a new whistle design is hitting the scene, aiming to make coaches’ calls clearer amidst the chaos of overlapping games. But let’s not get lost in the novelty—this isn’t just about some fancy gadget; it’s got implications worth dissecting. First up, this invention is supposedly patent-pending. That tag usually raises eyebrows in finance...

Continue Reading
UK Imposes Sanctions on Russian Military for Chemical Warfare

Updated Category News Views 119

UK Sanctions Against Russian Military Forces The UK government has taken a bold step to address the ongoing situation in Ukraine by imposing sanctions on Russian military personnel linked to the use of chemical weapons on the battlefield. This decisive action showcases the UK's commitment to upholding international law and protecting human rights. Targeted Sanctions on...

Continue Reading
PepsiCo Prepares for Challenging Q3 Amid Pricing Pressures

Updated Category News Views 296

PepsiCo's Current Market Position PepsiCo, Inc. (NASDAQ: PEP) continues to show resilience as it navigates a complex economic environment. Recently, the company’s shares have been trading slightly higher, reflecting a degree of investor confidence amidst ongoing market challenges. Analyst Insights on Upcoming Earnings According to analyst Peter T. Galbo from BofA...

Continue Reading